Cargando…
Reduced NCOR2 expression accelerates androgen deprivation therapy failure in prostate cancer
This study addresses the roles of nuclear receptor corepressor 2 (NCOR2) in prostate cancer (PC) progression in response to androgen deprivation therapy (ADT). Reduced NCOR2 expression significantly associates with shorter disease-free survival in patients with PC receiving adjuvant ADT. Utilizing t...
Autores principales: | Long, Mark D., Jacobi, Justine J., Singh, Prashant K., Llimos, Gerard, Wani, Sajad A., Rowsam, Aryn M., Rosario, Spencer R., Hoogstraat, Marlous, Linder, Simon, Kirk, Jason, Affronti, Hayley C., Bergman, Andries, Zwart, Wilbert, Campbell, Moray J., Smiraglia, Dominic J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8889623/ https://www.ncbi.nlm.nih.gov/pubmed/34910907 http://dx.doi.org/10.1016/j.celrep.2021.110109 |
Ejemplares similares
-
JAZF1: A Metabolic Regulator of Sensitivity to a Polyamine-Targeted Therapy
por: Rosario, Spencer R., et al.
Publicado: (2023) -
Pharmacological polyamine catabolism upregulation with methionine salvage pathway inhibition as an effective prostate cancer therapy
por: Affronti, Hayley C., et al.
Publicado: (2020) -
Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas
por: Rosario, S. R., et al.
Publicado: (2018) -
Functional mapping of androgen receptor enhancer activity
por: Huang, Chia-Chi Flora, et al.
Publicado: (2021) -
Hormone stimulation of androgen receptor mediates dynamic changes in DNA methylation patterns at regulatory elements
por: Dhiman, Vineet K., et al.
Publicado: (2015)